Fact CheckerSign in

NCT06794840Not yet recruiting

JomCare Study - A Harm Reduction Study

Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
482 (estimated)
First submitted
23 Jan 2025
Start date
1 Nov 2026
Primary completion date
30 May 2029
Lead sponsor
University of Connecticut
Diseases
HIV
NCT number
NCT06794840

What you commit to

  • Study type: Interventional
  • Planned participants: 482
  • From 1 Nov 2026 to the primary completion date, 30 May 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Enrolled in drug rehabilitation, substance use treatment, and narcotics or other behavioral intervention-based treatment

Other

  • Unable to provide informed consent
  • Unable to read and understand English or Bahasa Malaysia

Who the study is looking for

  • Age ≥18 years;
  • Cisgender man;
  • HIV-negative or HIV status unknown;
  • Having engaged in "chemsex" in the past 12 months (defined as using CAD, including crystal methamphetamine, mephedrone, GBL/GHB, and/or ecstasy/MDMA)
  • Own a smartphone

Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Malaya
Coordinator of this site? Confirm its status
Kuala LumpurMalaysiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.